#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatitis B Neuroblastoma Osteosarcoma Arginase deficiency Extra-osseous Ewing's sarcoma metastatic Emphysema Warm autoimmune haemolytic anaemia Intracranial calcification Chordoma Skin angiosarcoma Osteopetrosis Palmar-plantar erythrodysaesthesia syndrome Soft tissue sarcoma Andersen-Tawil syndrome Pseudomyxoma peritonei More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Basic Information Hereditary motor and sensory neuropathy – Trials in Disease Activated PI3 kinase delta syndrome – Trials in Disease Angiosarcoma – Life with Disease Acute respiratory distress syndrome – Life with Disease Noonan syndrome – Life with Disease Haemophilia A without inhibitors – Basic Information Bronchopulmonary dysplasia – Diagnostics Soft tissue sarcoma – Life with Disease Angiosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000008866 6QC-ICG Pegunigalsidase Alfa Lamivudine Azd4831 Emraclidine Cd7-Cart01 Metoprolol Succinate Crisantaspase Nido-361 Clavulanic Acid Ima402 Eliglustat Tartrate PRT3789 ADCE-D01 Efavirenz Azd9550 [18F]Alf-Nota-Octreotide Bexmarilimab Pramlintide Acetate More therapies…

    Learn about Your Condition

    Gastric cancer Hyperlipidaemia Acarodermatitis Seasonal allergy Biliary adenoma Mantle cell lymphoma recurrent Hairy cell leukaemia recurrent Cerebral haemorrhage Osteogenesis imperfecta Pancreatic failure Lichen planus Haemolytic uraemic syndrome Neuropathic arthropathy Growth hormone deficiency Anal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Stomatognathic Diseases

  • Study on the Safety and Tolerability of Tamoxifen in Cystic Fibrosis Patients Not Eligible for CFTR Modulator Therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tamoxifen
    Italy

  • Study on High-Dose Vitamin D3 and Glycerol for Improving Wound Healing After Wisdom Tooth Removal in Patients with Vitamin D Insufficiency

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitamin D deficiency
    Investigated Drugs:
    • Glycerol
    • Colecalciferol
    Austria

  • Study on Clostridium Botulinum Neurotoxin Type A for Treating Myalgia and Myofascial Pain in Patients with Temporomandibular Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myofascial pain syndrome
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Sweden

  • Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    • Paracetamol
    Sweden

  • Study on Clonazepam for Treating Burning Mouth Syndrome in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Burning mouth syndrome
    Investigated Drugs:
    • Clonazepam
    Sweden

  • Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

    Recruiting

    3 1
    Investigated Diseases:
    • Gingival bleeding
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    Croatia Hungary Romania Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!